Passer au contenu

/ Pharmacie 100 ans d'excellence

Je donne

Rechercher

Amélie Marsot

Vcard

Professeure adjointe

Faculté de pharmacie

Pavillon Jean Coutu office 3204

amelie.marsot@umontreal.ca

514 343-6111 #3253

Diplôme de Pédagogie Médicale
2013 , Éducation , Aix Marseille Université (France)

Doctorat d'Université Recherche Clinique et Santé Publique
2012 , Pharmacologie, Santé publique , Aix Marseille Université (France)

Diplôme InterUniversitaire Formation des Investigateurs aux Essais Cliniques des Médicaments
2011 , Sciences cliniques , Aix Marseille Université (France)

Master 2 Pharmacocinétique
2009 , Pharmacologie , Université de la Méditerranée (France)

Expertises

Responsabilities and outreach Expand all Collapse all

Activités au sein d’organismes ou d’entités de l’institution
Titres : corporations et organismes professionnels

Research projects Expand all Collapse all

Développement d'un programme de suivi thérapeutique pharmacologique et pharmacocinétique des anti-infectieux Projet de recherche au Canada / 2019 - 2021

Lead researcher : Amélie Marsot
Funding sources: FCI/Fondation canadienne pour l'innovation
Grant programs: PVXXXXXX-Fonds des leaders

RQRM - Appel à projet 2019 Axe Biopharmacie et Pharmacométrie pharmacothérapie de précision des aminglycosides en unités de soins intensifs. Projet de recherche au Canada / 2019 - 2020

Lead researcher : Chantale Simard
Co-researchers : Amélie Marsot
Funding sources: FRQS/Fonds de recherche du Québec - Santé (FRSQ)
Grant programs: PVXXXXXX-Réseaux thématiques de recherche

Publications Expand all Collapse all

Thirion DJG, Pasche V, Marsot A. What is the recommended amikacin dosing for cystic fibrosis patients with acute pulmonary exacerbations? Pediatr Pulmonol. 2019 Jul 16. doi: 10.1002/ppul.24453.

Marsot A. Pharmacokinetic Variability in Pediatrics and Intensive Care: Toward a Personalized Dosing Approach. J Pharm Pharm Sci. 2018;21(1):354-362.

Riff C, Bourgoin A, Marsot A, Allanioux L, Leone M, Blin O, Guilhaumou R. Population pharmacokinetic model for tumescent lidocaine in women undergoing breast cancer surgery. Eur J Clin Pharmacol. 2018 Jun 16. doi: 10.1007/s00228-018-2503-8

Marsot A, Gallais F, Galambrun C, Coze C, Blin O, Andre N, Guilhaumou R. Vancomycin in Pediatric Patients with Solid or Hematological Malignant Disease: Predictive Performance of a Population Pharmacokinetic Model and New Optimized Dosing Regimens. Paediatr Drugs. 2018 May 8. doi: 10.1007/s40272-018-0295-z.

Riff C, Guilhaumou R, Marsot A, Beaussier M, Cohen M, Blin O, Francon D. Ropivacaine wound infiltration for pain management after breast cancer mastectomy: a population pharmacokinetic analysis. Clin Pharmacol Drug Dev. 2018 Apr 16. doi: 10.1002/cpdd.452.

Marsot A, Guilhaumou R, Azulay JP, Blin O. Levodopa in Parkinson's Disease: A Review of Population Pharmacokinetics/Pharmacodynamics Analysis. Journal of Pharmacy and Pharmaceutical Sciences 2017;20(0):226-238. doi: 10.18433/J30H04. 

Toullec L, Dupouey J, Vigne C, Marsot A, Allanioux L, Blin O, Leone M, Guilhaumou R. Analytical interference during cefepime therapeutic drug monitoring in intensive care patient: About a case report. Therapie. 2017 Mar 30. pii: S0040-5957(17)30056-2. doi: 10.1016/j.therap.2017.02.003. [Epub ahead of print]

Marsot A, Michel F, Chasseloup E, Paut O, Guilhaumou R, Blin O. Phenobarbital in intensive care unit pediatric population: Predictive performances of population pharmacokinetic model. Fundam Clin Pharmacol. 2017 Apr 13. doi: 10.1111/fcp.12291. 

Marsot A, Audebert C, Attolini L, Lacarelle B, Micallef J, Blin O. Population pharmacokinetics model of THC used by pulmonary route in occasional cannabis smokers.J Pharmacol Toxicol Methods. 2017 Feb 4;85:49-54. doi: 10.1016/j.vascn.2017.02.003. 

Gueyffier F, Piedbois P, Bergmann JF; les participants à la table ronde n° 2 de Giens XXXII. Comment mesure-t-on le bénéfice net d’un traitement ?Therapie. 2017 Jan 3. pii: S0040-5957(16)31273-2. doi: 10.1016/j.therap.2016.11.057.

Gueyffier F, Piedbois P, Bergmann JF; participants of Giens XXXII Round Table No. 2. How to measure the net benefit of treatment?Therapie. 2017 Jan 3. pii: S0040-5957(16)31275-6. doi: 10.1016/j.therap.2016.12.004. 

A. MarsotQ. BoucherieF. KheloufiC. RiffD. BraunsteinJ. DupoueyR. GuilhaumouX. ZendjidjianS. Bonin-GuillaumeE. FakraM. GuyeV. JirsaJ.-M. AzorinR. BelzeauxM. Adida,J. MicallefO. Blin  Que peut-on attendre des essais cliniques en psychiatrie ? L’Encéphale, 42(6)S Dec 2016 : S2-S6 Les essais cliniques en psychiatrie : état des lieux et perspectives Marseille 2016 

Marsot A, Ménard A, Dupouey J, Riff C, Guilhaumou R and Blin O.Population pharmacokinetic of rifampicin in adult patients with osteoarticular infections: interaction with fusidic acid. British Journal of Clinical Pharmacology 2016 Nov 4. doi: 10.1111/bcp.13178. [Epub ahead of print] 

Marsot A, Audebert C, Attolini L, Lacarelle B,  Micallef J, Blin O. Comparison of cannabinoid concentrations in plasma, oral fluid and urine in occasional cannabis smokers after smoking cannabis cigarette Journal of Pharmacy and Pharmaceutical Sciences 2016 Jul - Sep;19(3):411-422. 

Guilhaumou R, Marsot A, Dupouey J, Galambrun C, Boulamery A, Coze C, Simon N, Andre N. Pediatric patients with solid or haematological tumor disease: vancomycin population pharmacokinetics and dosage optimization. Therapeutic Drug Monitoring 2016 Oct; 38(5):559-66 

Marsot A, Guilhaumou R, Riff C, Blin O. Amikacin in critically ill patients: A review from population pharmacokinetics analysis. Clinical Pharmacokinetics 2017 Feb; 56(2):127-138. doi:10.1007/s40262-016-0428-x 

Marsot A, Simon N. Nicotine and cotinine levels with electronic cigarette: A review Int J Toxicol. 2016; 35(2):179-85 

Imbert B, Marsot A, Liachenko N, Simon N..Population pharmacokinetics of high-dose oxazepam in alcohol-dependent patients : is there a risk of accumulation ?Therapeutic Drug Monitoring 2016; 38(2):253-8

Scala C , Marsot A, Limoges MJ, Locatelli Y, Simon N, Alvarez JC.Population pharmacokinetics of methadone hydrochloride after a single intramuscular administration in adult Japanse sika deer (Cervus nippon nippon). Veterinary Anaesthesia and Analgesia 2014; 42(2):165-72 

Collège des Enseignants de Pharmacologie (Multi auteurs) Aide-mémoire PACES UE6 Initiation à la connaissance du médicament Editions Vernazobres-Grego, Janvier 2014 - ISBN: 978-2-8183-1121-9

Marsot A, Imbert B, Alvarez JC, Grassin-Delyle S, Jaquet I, Lancon C, Simon N.High variability in the exposure of baclofen in alcohol dependent patients. Alcoholism: Clinical and Experimental Research 2014; 38(2):316-21

Marsot A, Brévaut-Malaty V, Vialet R, Boulamery A, Bruguerolle B, Simon N. Pharmacokinetics and absolute bioavailability of phenobarbital in neonates and young infants, a population pharmacokinetic modelling approach. Fundamental and Clinical Pharmacology 2013; June 14 

Marsot A, Goirand F, Milési N, Dumas M, Boulamery A, Simon N. Interaction of thiopental with esomeprazole in critically ill patients. European Journal Clinical Pharmacology 2013; 69 (9): 1667-72

Boulamery A, Marsot A, Bruguerolle B, Marouani H, Rocher E, Simon N. Population pharmacokinetics of ertapenem in juvenile and old rats. Fundam Clin Pharmacol 2013; May5

Marsot A, Boulamery A, Bruguerolle B, Simon N. Population pharmacokinetic analysis during the first two years of life: an overview. Clinical Pharmacokinetics 2012; 51(12):787-98

Simon N, Marsot A,Villard E, Choquet S, Khe HX, Zahr N, Lechat P, Leblond V, Hulot JS. Impact of ABCC2 polymorphisms on high-dose methotrexate pharmacokinetics in patients with lymphoid malignancy. The Pharmacogenomics Journal 2013; 13(6):507-13

Marsot A, Vialet R, Boulamery A, Bruguerolle B, Simon N. Vancomycin: Predictive performance of a population pharmacokinetic model and optimal dose in neonates and young infants. Clinical Pharmacology in Drug Development 2012; 1(4): 144-151.

Perus O, Marsot A, Ramain E, Dahman M, Paci A, Raucoules-Aimé M, Simon N. Performance of alfentanil target-controlled infusion in normal and morbidly obese female patients. British Journal of Anaesthesia 2012; 109(4): 551-60.

Marsot A, Boulamery A, Bruguerolle B, Simon N. Vancomycin : A review of population pharmacokinetic analyses. Clinical Pharmacokinetics 2012; 51(1): 1-13

Additional Information

Browse this profile on: